Literature DB >> 9295347

Identification and functional reconstitution of the type 2 inositol 1,4,5-trisphosphate receptor from ventricular cardiac myocytes.

P J Perez1, J Ramos-Franco, M Fill, G A Mignery.   

Abstract

The inositol 1,4,5-trisphosphate receptor (InsP3R) is an intracellular Ca2+ release channel that mediates the rise in cytoplasmic calcium in response to receptor-activated production of InsP3. The InsP3R-mediated signaling pathway appears to be ubiquitous and is involved in many cellular processes including cell division, smooth muscle contraction, and neuronal signaling. Different regions of the heart also express InsP3 receptors. We report here that acutely dissociated ventricular myocytes from ferret and rat hearts express significant levels of InsP3R as indicated by immunoblotting with a receptor consensus antibody. InsP3 binding experiments (KD = 23.6 nM and Bmax = 0.46 pmol/mg) suggest the myocytes contain the high affinity type 2 InsP3 receptor. Exhaustive mRNA screening by polymerase chain reaction, RNase protection, and subsequent DNA sequencing positively identify the InsP3R as type 2. The type 2 receptor from ferret heart was then incorporated into planar lipid bilayers and formed Ca2+-selective, InsP3-activated, heparin-blocked ion channels. We conclude that the predominant InsP3 receptor isoform expressed in cardiac myocytes is type 2 and that it forms a functional InsP3-gated Ca2+ channel when reconstituted in planar lipid bilayers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9295347     DOI: 10.1074/jbc.272.38.23961

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Single-channel function of recombinant type 2 inositol 1,4, 5-trisphosphate receptor.

Authors:  J Ramos-Franco; D Bare; S Caenepeel; A Nani; M Fill; G Mignery
Journal:  Biophys J       Date:  2000-09       Impact factor: 4.033

Review 2.  CaMKII in myocardial hypertrophy and heart failure.

Authors:  Mark E Anderson; Joan Heller Brown; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2011-01-27       Impact factor: 5.000

3.  Reaction diffusion modeling of calcium dynamics with realistic ER geometry.

Authors:  Shawn Means; Alexander J Smith; Jason Shepherd; John Shadid; John Fowler; Richard J H Wojcikiewicz; Tomas Mazel; Gregory D Smith; Bridget S Wilson
Journal:  Biophys J       Date:  2006-04-14       Impact factor: 4.033

4.  Pacemaking, arrhythmias, inotropy and hypertrophy: the many possible facets of IP3 signalling in cardiac myocytes.

Authors:  H Llewelyn Roderick; Martin D Bootman
Journal:  J Physiol       Date:  2007-04-19       Impact factor: 5.182

Review 5.  Inositol trisphosphate receptor Ca2+ release channels.

Authors:  J Kevin Foskett; Carl White; King-Ho Cheung; Don-On Daniel Mak
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

6.  Isoform-specific function of single inositol 1,4,5-trisphosphate receptor channels.

Authors:  J Ramos-Franco; M Fill; G A Mignery
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

7.  Type III InsP3 receptor channel stays open in the presence of increased calcium.

Authors:  R E Hagar; A D Burgstahler; M H Nathanson; B E Ehrlich
Journal:  Nature       Date:  1998-11-05       Impact factor: 49.962

Review 8.  The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca²⁺-release channel.

Authors:  Tamara Vervloessem; David I Yule; Geert Bultynck; Jan B Parys
Journal:  Biochim Biophys Acta       Date:  2014-12-10

9.  Diabetes decreases mRNA levels of calcium-release channels in human atrial appendage.

Authors:  Sahika Guner; Ebru Arioglu; Aydin Tay; Atalay Tasdelen; Sait Aslamaci; Keshore R Bidasee; U Deniz Dincer
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

10.  Single channel function of recombinant type-1 inositol 1,4,5-trisphosphate receptor ligand binding domain splice variants.

Authors:  J Ramos-Franco; S Caenepeel; M Fill; G Mignery
Journal:  Biophys J       Date:  1998-12       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.